Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Ca2+ binding to site I of the cardiac Ca2+ pump is sufficient to dissociate phospholamban.

Chen Z, Akin BL, Jones LR.

J Biol Chem. 2010 Jan 29;285(5):3253-60. doi: 10.1074/jbc.M109.080820. Epub 2009 Nov 30.

2.
3.

Use of glycerol-containing media to study the intrinsic fluorescence properties of detergent-solubilized native or expressed SERCA1a.

Montigny C, Arnou B, Marchal E, Champeil P.

Biochemistry. 2008 Nov 18;47(46):12159-74. doi: 10.1021/bi8006498. Epub 2008 Oct 24.

PMID:
18947188
4.

Structural aspects of ion pumping by Ca2+-ATPase of sarcoplasmic reticulum.

Toyoshima C.

Arch Biochem Biophys. 2008 Aug 1;476(1):3-11. doi: 10.1016/j.abb.2008.04.017. Epub 2008 Apr 18. Review.

PMID:
18455499
5.

Crystal structure of D351A and P312A mutant forms of the mammalian sarcoplasmic reticulum Ca(2+) -ATPase reveals key events in phosphorylation and Ca(2+) release.

Marchand A, Winther AM, Holm PJ, Olesen C, Montigny C, Arnou B, Champeil P, Clausen JD, Vilsen B, Andersen JP, Nissen P, Jaxel C, Møller JV, le Maire M.

J Biol Chem. 2008 May 23;283(21):14867-82. doi: 10.1074/jbc.M710165200. Epub 2008 Mar 20.

6.

Phospholamban oligomerization, quaternary structure, and sarco(endo)plasmic reticulum calcium ATPase binding measured by fluorescence resonance energy transfer in living cells.

Kelly EM, Hou Z, Bossuyt J, Bers DM, Robia SL.

J Biol Chem. 2008 May 2;283(18):12202-11. doi: 10.1074/jbc.M707590200. Epub 2008 Feb 19.

7.
8.

Conformational fluctuations of the Ca2+-ATPase in the native membrane environment. Effects of pH, temperature, catalytic substrates, and thapsigargin.

Inesi G, Lewis D, Toyoshima C, Hirata A, de Meis L.

J Biol Chem. 2008 Jan 11;283(2):1189-96. Epub 2007 Nov 9.

9.

Förster transfer recovery reveals that phospholamban exchanges slowly from pentamers but rapidly from the SERCA regulatory complex.

Robia SL, Campbell KS, Kelly EM, Hou Z, Winters DL, Thomas DD.

Circ Res. 2007 Nov 26;101(11):1123-9. Epub 2007 Nov 1.

10.
11.

Phospholamban inhibits Ca-ATPase conformational changes involving the E2 intermediate.

Waggoner JR, Huffman J, Froehlich JP, Mahaney JE.

Biochemistry. 2007 Feb 20;46(7):1999-2009. Epub 2007 Jan 30.

PMID:
17261028
12.

The molecular basis for cyclopiazonic acid inhibition of the sarcoplasmic reticulum calcium pump.

Moncoq K, Trieber CA, Young HS.

J Biol Chem. 2007 Mar 30;282(13):9748-57. Epub 2007 Jan 26.

13.

Modulatory and catalytic modes of ATP binding by the calcium pump.

Jensen AM, Sørensen TL, Olesen C, Møller JV, Nissen P.

EMBO J. 2006 Jun 7;25(11):2305-14. Epub 2006 May 18.

15.

The effects of mutation on the regulatory properties of phospholamban in co-reconstituted membranes.

Trieber CA, Douglas JL, Afara M, Young HS.

Biochemistry. 2005 Mar 8;44(9):3289-97.

PMID:
15736939
16.
17.

Phospholamban: a crucial regulator of cardiac contractility.

MacLennan DH, Kranias EG.

Nat Rev Mol Cell Biol. 2003 Jul;4(7):566-77. Review.

PMID:
12838339
18.

Defining the molecular components of calcium transport regulation in a reconstituted membrane system.

Reddy LG, Cornea RL, Winters DL, McKenna E, Thomas DD.

Biochemistry. 2003 Apr 22;42(15):4585-92.

PMID:
12693956
19.

Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase.

Toyoshima C, Asahi M, Sugita Y, Khanna R, Tsuda T, MacLennan DH.

Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):467-72. Epub 2003 Jan 13.

20.

Supplemental Content

Support Center